Shiro Takamatsu
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 4
- Oncology top 10%
- PARP inhibition in cancer therapy 7
- Cancer Immunotherapy and Biomarkers 4
-
- Cancer Genomics and Diagnostics 4
-
- Endometrial and Cervical Cancer Treatments 3
-
- DNA Repair Mechanisms 4
- RNA modifications and cancer 3
- CRISPR and Genetic Engineering 3
Shiro Takamatsu
21 papers receiving 407 citations
Peers
Comparison fields: 5 of 52
- Reproductive Medicine 93
- Oncology 273
- Immunology 139
- Cancer Research 78
- Obstetrics and Gynecology 29
Countries citing papers authored by Shiro Takamatsu
This map shows the geographic impact of Shiro Takamatsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Takamatsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Takamatsu more than expected).
Fields of papers citing papers by Shiro Takamatsu
This network shows the impact of papers produced by Shiro Takamatsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Takamatsu. The network helps show where Shiro Takamatsu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shiro Takamatsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 5 | |
| 8 | 2023 | 12 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 7 | |
| 12 | 2023 | 5 | |
| 13 | 2022 | 4 | |
| 14 | 2022 | 119 | |
| 15 | 2021 | 38 | |
| 16 | 2021 | 6 | |
| 17 | 2021 | 1 | |
| 18 | 2020 | 6 | |
| 19 | 2020 | 133 | |
| 20 | 2013 | 5 |
About Shiro Takamatsu
Shiro Takamatsu is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology, having authored 26 papers that have together received 413 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (7 papers), DNA Repair Mechanisms (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Ovarian cancer diagnosis and treatment (4 papers), Cancer Genomics and Diagnostics (4 papers), Endometrial and Cervical Cancer Treatments (3 papers), RNA modifications and cancer (3 papers) and CRISPR and Genetic Engineering (3 papers). The work is most often cited by research in Reproductive Medicine (93 citations), Oncology (273 citations) and Immunology (139 citations). Shiro Takamatsu has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Masaki Mandai, Noriomi Matsumura, Hidekatsu Nakai, Hisamitsu Takaya, Ken Yamaguchi, Junzo Hamanishi, Koji Yamanoi, Kaoru Abiko, Yuko Hosoe and Masayo Ukita. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.